A Study of RSLV-132 in Subjects With Primary Sjogren's Syndrome

NCT03247686 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Sjogren's Syndrome

Interventions

DRUG: RSLV-132
DRUG: Placebo

Sponsor

Resolve Therapeutics

Collaborators

[object Object]
[object Object]